Contracts › 75N91023F00008
75N91023F00008: The Objective of This Task Order Supports Niaids Goal to Conduct a Series of Standardized Phase 1 and Phase 2 Trials on Next-Generation Vaccines to Generate Data to Inform Decisions on Which Candidates to Support for Advanced Development.
Awarded to Leidos Biomedical Research Inc by National Institutes of Health (NIH).
$173.3Mobligated
$173.3Mpotential value
31 May 2029current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N91023F00008 |
|---|---|
| Vehicle | 75N91019D00024 |
| Awardee | Leidos Biomedical Research Inc |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NIH NCI |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | MD |
| Period of performance | 01 June 2023 to 31 May 2029 |
| Potential end | 31 May 2029 |
| Estimated recompete solicitation | ~Q4 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record